Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 1
Submit an article Journal homepage
622
Views
9
CrossRef citations to date
0
Altmetric
Clinical Immunology

Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria

Liya WangHealthCore, Inc., Wilmington, DE, USA;
,
Xuehua KeHealthCore, Inc., Wilmington, DE, USA; Correspondence[email protected]
,
Abhishek KavatiNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
,
Debra WertzHealthCore, Inc., Wilmington, DE, USA;
,
Qing HuangHealthCore, Inc., Wilmington, DE, USA;
,
Vincent J. WilleyHealthCore, Inc., Wilmington, DE, USA;
,
Judith J. StephensonHealthCore, Inc., Wilmington, DE, USA;
,
Benjamin OrtizNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
,
Brandee PaknisNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
,
Jonathan A. BernsteinBernstein Clinical Research Center, LLC, Cincinnati, OH, USA;
&
Lisa A. BeckUniversity of Rochester Medical Center, Rochester, NY, USA
 show all
Pages 35-39 | Received 20 Sep 2017, Accepted 19 Oct 2017, Published online: 10 Nov 2017

References

  • Vietri J, Turner SJ, Tian H, et al. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey. Ann Allergy Asthma Immunol 2015;115:306-11
  • Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011;128:202-209.e5
  • Powell RJ, Leech SC, Till S, et al. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exper Allergy 2015;45:547-65
  • Moolani Y, Lynde C, Sussman G. Advances in understanding and managing chronic urticaria. F1000Res. 2016 Feb 16;5. pii: F1000 Faculty Rev-177.
  • Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009;64:1427-43
  • Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol 2014;133:1270-7
  • Genentech. Xolair prescribing information [Internet]. 2015. South San Francisco, California, United States: Genentech, Inc. Available online at: http://www.gene.com/download/pdf/xolair_prescribing.pdf. Accessed March 30, 2016
  • Kaplan A, Ledford D, Ashby M, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 2013;132:101-9
  • Maurer M, Rosen K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013;368:924-35
  • Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011;128:567-73.e1
  • Anthem. Anthem Xolair Medical Policy [Internet]. Anthem; 2015. Indianapolis, Indiana, United States: Anthem, Inc. Available online at: https://www.anthem.com/medicalpolicies/policies/mp_pw_a050293.htm. Accessed March 30, 2016
  • Viswanathan RK, Moss MH, Mathur SK. Retrospective analysis of the efficacy of omalizumab in chronic refractory utricaria. Allergy Asthma Proc 2013;34:446-52
  • Clark JJ, Secrest AM, Hull CM, et al. The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: retrospective chart review. J Am Acad Dermatol 2016;74:1274-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.